171 related articles for article (PubMed ID: 37358683)
41. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
42. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
World J Surg Oncol; 2017 Jul; 15(1):118. PubMed ID: 28673296
[TBL] [Abstract][Full Text] [Related]
43. The 21-gene recurrence score and locoregional recurrence in breast cancer patients.
Jegadeesh NK; Kim S; Prabhu RS; Oprea GM; Yu DS; Godette KG; Zelnak AB; Mister D; Switchenko JM; Torres MA
Ann Surg Oncol; 2015 Apr; 22(4):1088-94. PubMed ID: 25472643
[TBL] [Abstract][Full Text] [Related]
44. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.
Mahmood U; Morris C; Neuner G; Koshy M; Kesmodel S; Buras R; Chumsri S; Bao T; Tkaczuk K; Feigenberg S
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1387-93. PubMed ID: 22300561
[TBL] [Abstract][Full Text] [Related]
45. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
46. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
47. Second invasive breast cancers in patients treated with breast-conserving therapy.
Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
[TBL] [Abstract][Full Text] [Related]
48. Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.
Arsenault D; Hurley J; Takita C; Reis IM; Zhao W; Rodgers S; Wright JL
Am J Clin Oncol; 2015 Aug; 38(4):348-52. PubMed ID: 23799288
[TBL] [Abstract][Full Text] [Related]
49. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.
Braunstein LZ; Taghian AG; Niemierko A; Salama L; Capuco A; Bellon JR; Wong JS; Punglia RS; MacDonald SM; Harris JR
Breast Cancer Res Treat; 2017 Jan; 161(1):173-179. PubMed ID: 27807809
[TBL] [Abstract][Full Text] [Related]
50. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results.
Jatoi I; Proschan MA
Am J Clin Oncol; 2005 Jun; 28(3):289-94. PubMed ID: 15923803
[TBL] [Abstract][Full Text] [Related]
51. Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status.
Zetterlund L; Celebioglu F; Hatschek T; Frisell J; de Boniface J
Br J Surg; 2021 May; 108(5):583-589. PubMed ID: 34043772
[TBL] [Abstract][Full Text] [Related]
52. Is mastectomy superior to breast-conserving treatment for young women?
Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
[TBL] [Abstract][Full Text] [Related]
53. 10-Year Survival after Breast-Conserving Surgery Compared with Mastectomy in Louisiana Women with Early-Stage Breast Cancer: A Population-Based Study.
Chu QD; Hsieh MC; Lyons JM; Wu XC
J Am Coll Surg; 2021 Apr; 232(4):607-621. PubMed ID: 33301909
[TBL] [Abstract][Full Text] [Related]
54. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
Swisher SK; Vila J; Tucker SL; Bedrosian I; Shaitelman SF; Litton JK; Smith BD; Caudle AS; Kuerer HM; Mittendorf EA
Ann Surg Oncol; 2016 Mar; 23(3):749-56. PubMed ID: 26511263
[TBL] [Abstract][Full Text] [Related]
55. Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.
Kim S; Park HS; Kim JY; Ryu J; Park S; Kim SI
Yonsei Med J; 2016 Sep; 57(5):1192-8. PubMed ID: 27401651
[TBL] [Abstract][Full Text] [Related]
56. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy.
Keruakous AR; Sadek BT; Shenouda MN; Niemierko A; Abi Raad RF; Specht M; Smith BL; Taghian AG
Breast Cancer Res Treat; 2014 Jul; 146(2):365-70. PubMed ID: 24952906
[TBL] [Abstract][Full Text] [Related]
57. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
Jwa E; Shin KH; Kim JY; Park YH; Jung SY; Lee ES; Park IH; Lee KS; Ro J; Kim YJ; Kim TH
Cancer Res Treat; 2016 Oct; 48(4):1363-1372. PubMed ID: 26910473
[TBL] [Abstract][Full Text] [Related]
58. Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study.
Wang S; Zhang Y; Yin F; Wang X; Yang Z
Front Oncol; 2021; 11():741737. PubMed ID: 34790571
[TBL] [Abstract][Full Text] [Related]
59. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
[TBL] [Abstract][Full Text] [Related]
60. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
van Dongen JA; Voogd AC; Fentiman IS; Legrand C; Sylvester RJ; Tong D; van der Schueren E; Helle PA; van Zijl K; Bartelink H
J Natl Cancer Inst; 2000 Jul; 92(14):1143-50. PubMed ID: 10904087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
